Navigation Links
Response Biomedical Corp. - Year End 2007 Earnings Webcast and Conference Call - March 31, 2008
Date:3/19/2008

CALGARY, March 19 /PRNewswire-FirstCall/ - Notification of Year End 2007 Earnings Webcast and Conference Call event:

Response Biomedical Corp. (TSX: RBM)

Year End 2007 Earnings Webcast and Conference Call

March 31, 2008, 5:30 PM ET

To listen to this Webcast and Conference Call event, please enter http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2167880 in your web browser.

To participate in the live conference call please dial into either (604) 677-8677 or (800) 733-7571.

For a complete listing of upcoming and archived webcasts available through CNW Group, please visit our events calendar at http://www.newswire.ca/en/webcast/index.cgi. CNW's webcast of earnings calls is consistent with Market Regulation Services Inc. (RS) objectives of providing investors with material information broadly and quickly.

CONTACT: Response Biomedical Contacts: Bill Wickson, Manager, Investor Relations, Response Biomedical Corporation, Tel (604) 456-6073, Email: bwickson@responsebio.com; Brian Korb, Vice President, The Trout Group LLC, Tel: (646) 378-2923, Email: bkorb@troutgroup.com


'/>"/>
SOURCE CNW Webcasts
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
2. Study identifies key player in the bodys immune response to chronic stress
3. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
4. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
5. Merck & Co., Inc. Response to Todays New York Medicaid Suit
6. Maternal depression and controlling behavior associated with increased stress response in infants
7. Family history of alcoholism affects response to drug used to treat heavy drinking
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
10. PET scans can accurately detect a breast tumors response to chemotherapy
11. DNA damage response confers a barrier for viral tumorigenesis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...i Kessock receives President’s Service Award...ember 2, 2009 -- CS3 Technology, a leading profess...ions to businesses across the country, is pleased ... year at their company-wide retreat, CS3 recognize...This year, Cindi Kessock earned the President&rsqu...
(Date:12/3/2009)...nt studies have shown that sleep deprivation can r...f obesity. Treadmill desks have been show effectiv...ks while increasing the quality of sleep. , ... 2009 -- Two sleep studies illustrating the negati...eached independent conclusions which ignore the re...
(Date:12/3/2009)...ghtra Medical, Inc, a California based medical dev...ventral hernia repair system. Freedom Ventral is a...ich completely obviates the need for complex, time... (PRWEB) December 3, 2009 -- Insightra Medical, ...ay announced the launch of its new ventral hernia ...
(Date:12/3/2009)...ing a five pound gift anywhere in the world can ea... worldwide postage is free when you send an upscal... at www.oakanahouse.com . , ...nd gift to Paris, Perth or Punjab can easily set y...ars they can keep in their pocket when gift buyers...
(Date:12/3/2009)...Dec. 3 The Ensign Group,...s acquired three Texas skilled nursing facilities:...lthcare Center in McAllen, the 100-bed Alta Vista ...d the 95-bed Veranda Rehabilitation & Healthca...ecember 1, 2009. ,, (Logo: http://www.newscom...
Breaking Medicine News(10 mins):Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Treadmill Desks Lower Health Risks Caused by Lack of Sleep 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:Greg Lawson Americana Photography Gift Books Now Offered with Free Shipping Worldwide 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3
...t. 4 Robbins & Myers, Inc.,(NYSE: RBN ) announce...ular,quarterly cash dividend payment of $0.065 per...7 to shareholders of record as of October 16,2007....uipment and systems to the energy,chemical, pharma...
...t. 4 SRA International, Inc.,(NYSE: SRX ), a lea...ng,services and solutions to federal government or...ement an enterprise-wide infrastructure,architectu...f $59 million over three years if all options are,...
...e Oct. 9 gift to resource center is just part of w...for teens., WILSONVILLE, Ore., Oct. 4 On Tuesday... to an estimated $75,000 in furniture,arcade games...ty Youth Resource Center (SMYRC). Volunteer crews...
...tic Groups, Program Is the Drive for Decision, CH...nc.,(WASI) has announced plans to introduce a proa... the highly successful certification and marketing...istance, voluntary industry contributions, foundat...
...Oct. 4 Newly released,practice guidelines publish...servative approach to treating low-back pain and r... proven benefits. In light of these new,guidelines...ociation (ACA)., "As shown in the literature, chi...
...A Anyone who has ever tried to set up an internet... website, has experienced the default option, an e...alternative is actively chosen. , In an opinion ar...nt of Biostatistics and Epidemiology at the Univer...
Other Medicine News:Health News:Department of Justice Awards $59M Task Order to SRA 2Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 2Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 3Health News:Wild American Shrimp Board Agrees To Implement New Self-Funding Measures 2Health News:New Low-Back Pain Guidelines Should Encourage Patients to Utilize Spinal Manipulation 2Health News:Default options should be used to improve healthcare 2
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Multiple Myeloma Therapeut...p://www.reportlinker.com/p0164271/Multiple-Myeloma..., Given the severity, and relentless relapses o...pies and treatments to battle the disease and impr...
(Date:12/2/2009)...LES, December 2 Fountain...that it would initiate a programme of,regular upda...significant,progress which Fountain is making in t...provide shareholders with regular updates on the p...rs and others. , Fountain reports that it...
(Date:12/2/2009)...o., Dec. 2 AlloSource, one of the ...e and soft tissue allografts for use in surgical p...e cellular bone growth substitutes, today announce... as a float rider aboard the annual Donate Life fl...ade®. Manuel Salazar, a 29-year-old quadrupl...
Breaking Medicine Technology:Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 2Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 3Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 4Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 5Reportlinker Adds Multiple Myeloma Therapeutics - US Market Trends & Analysis 6Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 1Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 2Red Cross Offers Important Tips for Caring for Someone With the Flu 59551 3Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 1Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 2Institute of Medicine Report Concludes Smoke Free Laws Prevent Heart Attacks 3B Its Time to Make All Workplaces and Public Places Smoke Free 59547 3BioInformatics LLC New Report The Market Outlook for Research Products in FY2010 14491 1BioInformatics LLC New Report The Market Outlook for Research Products in FY2010 14491 2BioInformatics LLC New Report The Market Outlook for Research Products in FY2010 14491 3
...ditional Analysis Shows HUMIRA Effectively Treats ...Regardless of Age, Duration of Disease, Diagn...rapy, PARIS, Sept. 18 More psoriasis patients,ac...ent with HUMIRA(R),(adalimumab) compared to patien...presented at the European Academy of Dermatology a...
...NGAPORE, Sept. 18 S*BIO Pte Ltd today announced t...als of SB1518, a potent and,orally-active JAK2 inh...s,of lymphoma. These first Phase I trials for SB15... several leading clinical sites in the United,Stat...ients and are,designed to determine the maximum to...
Other Medicine Technology:Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 2Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 3Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 4Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 5Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 6Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 7Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment 8S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies 2
Toxo IgM EIA
Toxo IgG EIA
Pylori Detect IgG EIA
MonoFluo Legionella pneumophilia IFA Test
Medicine Products: